CB Insights
Technology Market Intelligence
Technology Market Intelligence
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2020-12-09 | Reneo Pharmaceuticals | Series B | $95M | Abingworth, Accelerator Life Science Partners, Aisling Capital, Amzak Health, Lundbeckfond Ventures, New Enterprise Associates, Pappas Ventures, RiverVest Venture Partners, Rock Springs Capital, and Undisclosed Investors |
| 2020-11-09 | Stargazer Pharmaceuticals | Series A | $57M | Canaan Partners, Pontifax, and venBIO |
| 2020-10-20 | Aristea Therapeutics | Series B | $39.62M | |
| 2020-09-17 | LAVA Therapeutics | Series C | $83M | Gilde Healthcare Partners, MRL Ventures, Pureos Bioventures, Redmile Group, Sanofi Ventures, Versant Ventures, and Ysios Capital Partners |
| 2020-08-12 | F2G | Unattributed VC - V | $60.8M | Advent Life Sciences, Brace Pharma Capital, Cowen, and Morningside Technology Ventures |
